Urothelial bladder cancer in young age group: Presentation, clinical behavior and outcome
DOI:
https://doi.org/10.22317/imj.v6i4.1205Keywords:
Urinary Bladder Neoplasms, Young Age Group, Presentation, Clinical Behavior, OutcomeAbstract
Objectives: The main aim of our study is to review the clinical presentation, histopathological features, staging and grading, as well as the recurrence, and progression (for 1 year) of UBC in patients less than 40 years age.
Methods: We retrospectively reviewed records of 42 newly diagnosed patients with UBC between May 2016 to May 2020 at the Rizgary Teaching hospital, and Zheen International hospital in Erbil city, Iraq.
Results: The mean age ± SD of the sample were 29.05 ± 7.05 years, ranging from 17 to 39 years. The median was 28.5 years. Patients were divided into three groups, Group I (6 patients) were aged ≤ 20 years, Group II (17 patients) were aged between 20-29 years old, and Group III (19 patients) were aged between 30-39 years old. The majority (78.6%) of the cases were males. Gross hematuria (73.8%) is the most common presenting symptom. The proportion of smoker patients was 61.9%. Significantly higher proportions of patients with lower grade and stage and small tumor size were detected that comparable with previous studies that support the bladder cancer in young-aged group with lower grade and stage. In one year follow up, the recurrence occurred in 6 (14.3%) of patients, just 2 of them progressed to a higher grade or stage.
Conclusion: The results suggested that young patients with UBC was expecting better prognosis than older patients.
References
Gosling JA, Harris PF, Humpherson JR, Whitmore I, Willan PL. Human Anatomy, Color Atlas and Textbook E-Book. Elsevier Health Sciences; 2016 Feb 27.
Martini F, Ober WC, Garrison CW, Welch K, Hutchings RT. Martini's atlas of the human body. Pearson/Benjamin Cummings; 2012.
Netter FH. The Netter Collection of Medical Illustrations: Urinary System: A Compilation of Paintings. Urinary System. Elsevier Saunders; 2012.
Richters A, Aben KK, Kiemeney LA. The global burden of urinary bladder cancer: an update. World journal of urology. 2020 Aug;38(8):1895-904. https://gco.iarc.fr/today/online-analysis- pie?v=2020&mode=cancer&mode_population=continents&population=900&populations=368&ke y=total&sex=0&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group %5B%5D=0&ages_group%5B%5D=17&nb_items=15&group_cancer=1&include_nmsc=1&includ e_nmsc_other=1&half_pie=0&donut=0 .
Obeyed H. Iraqi cancer registry. annual report. Iraq 2016. Republic of Iraq /Ministry of Health/Environment/ Iraqi Cancer Board
Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE. The 2016 WHO classification of tumours of the urinary system and male genital organs—part B: prostate and bladder tumours. European urology. 2016 Jul 1;70(1):106-19.
Montironi R, Lopez-Beltran A, Scarpelli M, Mazzucchelli R, Cheng L. 2004 World Health Organization classification of the noninvasive urothelial neoplasms: inherent problems and clinical reflections. european urology supplements. 2009 Apr 1;8(5):453-7.
Wen YC, Kuo JY, Chen KK, Lin AT, Chang YH, Hsu YS, Chang LS. Urothelial carcinoma of the urinary bladder in young adults—clinical experience at Taipei Veterans General Hospital. Journal of the Chinese Medical Association. 2005 Jun 1;68(6):272-5.
Telli O, Sarici H, Ozgur BC, Doluoglu OG, Sunay MM, Bozkurt S, Eroglu M. Urothelial cancer of bladder in young versus older adults: clinical and pathological characteristics and outcomes. The Kaohsiung journal of medical sciences. 2014 Sep 1;30(9):466-70.
Daugherty SE, Lacey Jr JV, Pfeiffer RM, Park Y, Hoover RN, Silverman DT. Reproductive factors and menopausal hormone therapy and bladder cancer risk in the NIH‐ AARP Diet and Health Study. International journal of cancer. 2013 Jul 15;133(2):462-72.
Li P, Chen J, Miyamoto H. Androgen receptor signaling in bladder cancer. Cancers. 2017 Feb;9(2):20.
Scosyrev E, Golijanin D, Wu G, Messing E. The burden of bladder cancer in men and women: analysis of the years of life lost. BJU international. 2012 Jan 1;109(1):57-62.
García-Closas M, Malats N, Silverman D, Dosemeci M, Kogevinas M, Hein DW, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. The Lancet. 2005 Aug 20;366(9486):649-59.
Islami F, Stoklosa M, Drope J, Jemal A. Global and regional patterns of tobacco smoking and tobacco control policies. European urology focus. 2015 Aug 1;1(1):3-16.
Koutros S, Kogevinas M, Friesen MC, Stewart PA, Baris D, Karagas MR, Schwenn M, Johnson A, Hosain GM, Serra C, Tardon A. Diesel exhaust and bladder cancer risk by pathologic stage and grade subtypes. Environment International. 2020 Feb 1;135:105346.
Davis R, Jones JS, Barocas DA, Castle EP, Lang EK, Leveillee RJ, Messing EM, Miller SD, Peterson AC, Turk TM, Weitzel W. Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. The Journal of urology. 2012 Dec;188(6S):2473- 81.
Brierley JD, Gospodarowicz MK, Wittekind C, editors. TNM classification of malignant tumours. John Wiley & Sons; 2017 Jan 17.
Erőzenci A, Ataus S, Pekyalcin A, Kural A, Talat Z, Solok V. Transitional cell carcinoma of the bladder in patients under 40 years of age. International Urology and Nephrology. 1994 Mar 1;26(2):179-82
Kontani K, Kawakami M, Nakajima T, Katsuyama T. Tobacco use and occupational exposure to carcinogens, but not N-acetyltransferase 2 genotypes are major risk factors for bladder cancer in the Japanese. Urological Research. 2001 Jun 1;29(3):199-204.
Iori F, De Dominicis C, Liberti M, Frioni D, Vahedi M, Leonardo C, De Nunzio C, Laurenti C. Superficial bladder tumors in patients under 40 years of age: clinical, prognostic and cytogenetic aspects. Urologia internationalis. 2001;67(3):224-7.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Iraq Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.